Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at the Wedbush PacGrow 2015 Healthcare Conference

CHAPEL HILL, N.C., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 29, 2015 16:04 ET | Source: Melinta Therapeutics, Inc.

Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., July 29, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 22, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Report Second Quarter 2015 Financial Results

CHAPEL HILL, N.C., July 22, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 07, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

Cempra Completes Patient Enrollment of Solitaire-IV Phase 3 Clinical Trial

CHAPEL HILL, N.C., July 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 26, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at the Jefferies 2015 Global Healthcare Conference

CHAPEL HILL, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 19, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference

CHAPEL HILL, N.C., May 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 12, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present Solithromycin Data at Two Upcoming Medical Conferences

CHAPEL HILL, N.C., May 12, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 30, 2015 16:04 ET | Source: Melinta Therapeutics, Inc.

Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 23, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Report First Quarter 2015 Financial Results

CHAPEL HILL, N.C., April 23, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 17, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at Two Upcoming Scientific Conferences

CHAPEL HILL, N.C., April 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...